查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1934990

腦部影像和神經影像市場－全球產業規模、佔有率、趨勢、機會及預測（按影像類型、最終用戶、地區和競爭格局分類，2021-2031年）

Brain Imaging and Neuroimaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Imaging Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球腦部影像和神經影像診斷市場預計將從 2025 年的 126.4 億美元成長到 2031 年的 184 億美元，複合年成長率為 6.46%。

這些產品包括各種非侵入性診斷技術，例如電腦斷層掃描 (CT) 和磁振造影(MRI)，旨在可視化中樞神經系統的結構和功能狀態。市場的主要驅動力是神經系統疾病發病率的上升和全球人口老化，這兩方面都推動了對早期、精準疾病檢測的需求。例如，世界衛生組織 (WHO) 報告稱，到 2024 年，全球將有超過三分之一的人口患有神經系統疾病，凸顯了對專業診斷干預措施的迫切需求。

市場概覽
預測期 2027-2031
市場規模：2025年 126.4億美元
市場規模：2031年 184億美元
複合年成長率：2026-2031年 6.46%
成長最快的細分市場 功能性磁振造影（fMRI）
最大的市場 北美洲

儘管存在這些成長要素，但由於購買和安裝診斷成像系統的高成本，市場仍面臨許多障礙。新興經濟體不完善的報銷政策和熟練放射科醫生的短缺，往往加劇了這一經濟負擔，從而限制了診斷工具的廣泛應用。因此，巨額資金需求和人才短缺仍然是不同經濟體廣泛採用先進神經影像技術的挑戰。

市場促進因素

全球腦部影像和神經影像診斷市場的主要促進因素是神經系統疾病和神經退化性疾病的日益普遍。全球人口老化導致中樞神經系統疾病的發生率不斷上升，對支持早期療育的先進診斷技術產生了強勁的需求。根據美國癌症協會估計，截至2025年1月，美國當年將診斷出約24,820例惡性腦或脊髓腫瘤病例。這種持續的疾病負擔使得廣泛使用高解析度影像系統（例如MRI和CT）來評估結構完整性並指南治療策略成為必要，從而維持了市場需求。

同時，技術的快速發展以及人工智慧（AI）在診斷流程中的應用正顯著推動市場擴張。人工智慧軟體透過加快影像重建速度、提高診斷準確率和實現異常自動檢測，徹底改變了神經影像學。根據AuntMinnie於2025年7月發布的報告顯示，美國食品藥物管理局（FDA）在2024年9月至2025年7月期間核准了核准種人工智慧醫療設備，其中放射學軟體佔81%。這些創新也得到了研發領域大量投資的支持。根據The Transmitter於2025年11月發布的報告顯示，美國國立衛生研究院（NIH）對神經科學計劃的資助預計將在2024年達到105億美元，這將為腦造影技術的持續創新創造有利環境。

市場挑戰

診斷影像系統的高昂實施和安裝成本是限制全球腦部影像和神經影像市場成長的主要障礙。磁振造影(MRI) 和電腦斷層掃描 (CT) 等先進診斷設備需要大量的資本支出，不僅包括初始購買費用，還包括昂貴的基礎設施維修和專業維護費用。這種經濟負擔限制了市場滲透率，尤其是在預算緊張的小規模醫療機構和發展中地區。因此，許多機構不願投資最新的神經影像技術，只能延長舊設備的使用壽命。

醫療機構財務狀況的惡化加劇了這種經濟壓力，直接阻礙了它們購買新設備的能力。根據美國醫院協會 (AHA) 預測，到 2024 年，醫院和醫療系統的現金週轉天數預計將比 2022 年初下降 28.3%，這將顯著限制它們投資於新的醫療技術和基礎設施的能力。流動性的減少迫使醫院推遲對高成本影像設備的投資，這直接減緩了全球神經影像領域的收入成長和普及速度。

市場趨勢

攜帶式和照護現場磁振造影系統的引入正在重塑市場格局，將神經影像檢查從傳統的放射科轉移到加護病房和偏遠地區。這種轉變滿足了無法安全轉運至高場磁振造影設備的患者對即時中風診斷和腦部監測的迫切需求，有效克服了諸如射頻屏蔽等基礎設施障礙。根據2025年3月報告，Hyperfine公司在2024年售出了48套商用Swoop可攜式磁振造影系統，由於醫院採用率的提高，實現了17%的收入成長。這些低場、輪式系統無需專用設施，使神經影像檢查更加普及，並支援在患者床邊直接進行更快速的臨床決策。

此外，隨著醫療機構尋求降低全球氦氣短缺和複雜冷卻管道基礎設施帶來的營運風險，無氦和無液磁共振成像（MRI）技術的興起勢頭強勁。這一趨勢引入了密封磁體技術，該技術僅需極少量冷卻劑，與傳統的濕式磁鐵相比，顯著降低了生命週期成本和安裝複雜性。根據皇家飛利浦公司2025年11月發布的新聞稿，該公司已在全球安裝了超過2000套1.5T BlueSeal無氦MRI系統，迄今已節省超過600萬公升液氦。這項技術革新確保了在供應中斷期間的持續運作，並支持永續性目標，使無氦磁鐵成為未來腦部造影設備的可靠標準。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

5. 全球腦部影像與神經影像市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 透過影像方法（功能性磁振造影（fMRI）、電腦斷層掃描（CT）、正子斷層掃描（PET）、腦電圖（EEG）、腦磁圖（MEG）、近紅外線光譜（NIRS））
    • 依最終使用者（醫院/診所、門診手術中心、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美腦部影像與神經影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲腦部影像與神經影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區腦部影像診斷與神經影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲腦部影像和神經影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲腦造影與神經影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球腦部影像與神經影像市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Varian Medical Systems
  • General Electric Company
  • Siemens AG
  • Philips Healthcare
  • Toshiba Medical Systems
  • Hitachi Medical Systems
  • Esaote SpA
  • Sanrad Medical Systems Pvt. Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 21426

The Global Brain Imaging and Neuroimaging Market is projected to expand from USD 12.64 Billion in 2025 to USD 18.40 Billion by 2031, reflecting a compound annual growth rate of 6.46%. These products encompass a variety of non-invasive diagnostic technologies, such as computed tomography and magnetic resonance imaging, which are designed to visualize the structural and functional status of the central nervous system. The market is primarily propelled by the increasing incidence of neurological disorders and an aging global population, both of which drive the demand for early and precise disease detection. For instance, the World Health Organization reported in 2024 that neurological conditions affected more than one in three people worldwide, underscoring the urgent necessity for specialized diagnostic interventions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 12.64 Billion
Market Size 2031USD 18.40 Billion
CAGR 2026-20316.46%
Fastest Growing SegmentFunctional Magnetic Resonance Imaging (fMRI)
Largest MarketNorth America

Despite these positive growth drivers, the market encounters significant hurdles due to the high costs associated with acquiring and installing imaging systems. This financial strain is frequently exacerbated by inadequate reimbursement policies and a shortage of skilled radiologists in emerging economies, factors that collectively limit the widespread implementation of these diagnostic tools. Consequently, the substantial capital requirements and workforce constraints continue to pose challenges to the broad adoption of advanced neuroimaging technologies across diverse economic regions.

Market Driver

A primary catalyst for the Global Brain Imaging and Neuroimaging Market is the rising prevalence of neurological and neurodegenerative diseases. As the global population ages, the frequency of central nervous system conditions is increasing, creating a strong demand for advanced diagnostic modalities that support early intervention. According to the American Cancer Society's January 2025 estimates, approximately 24,820 malignant brain or spinal cord tumors were expected to be diagnosed in the United States that year. This persistent disease burden necessitates the widespread use of high-resolution imaging systems like MRI and CT to assess structural integrity and guide treatment strategies, thereby sustaining market adoption.

Simultaneously, rapid technological progress and the integration of artificial intelligence into diagnostic workflows are significantly fueling market expansion. AI-enabled software has transformed neuroimaging by accelerating image reconstruction, enhancing diagnostic precision, and facilitating automated anomaly detection. As reported by AuntMinnie in July 2025, the FDA listed 211 AI-enabled medical devices cleared between September 2024 and July 2025, with radiology software accounting for 81% of these approvals. These innovations are further supported by substantial investment in research and development; The Transmitter noted in November 2025 that National Institutes of Health (NIH) funding for neuroscience projects reached $10.5 billion in 2024, creating an environment that fosters continuous innovation in brain imaging technologies.

Market Challenge

The substantial costs involved in acquiring and installing imaging systems present a formidable barrier to the growth of the Global Brain Imaging and Neuroimaging Market. Sophisticated diagnostic modalities, such as magnetic resonance imaging and computed tomography, require heavy capital expenditure that covers not only the initial purchase price but also expensive infrastructure modifications and specialized maintenance. This financial magnitude limits market penetration, particularly in smaller healthcare facilities and developing regions where budget constraints are severe. Consequently, many institutions are forced to extend the lifecycle of obsolete equipment rather than investing in modern neuroimaging technologies.

This economic pressure is further intensified by the declining financial stability of healthcare providers, which directly hinders the procurement of new equipment. According to the American Hospital Association, the number of days of cash on hand for hospitals and health systems dropped by 28.3% in 2024 compared to the start of 2022, severely restricting their ability to invest in new medical technology and infrastructure. This reduction in liquidity compels hospitals to deprioritize high-cost imaging investments, thereby directly slowing down revenue growth and adoption rates within the global neuroimaging sector.

Market Trends

The adoption of portable and point-of-care MRI systems is reshaping the market by moving neuroimaging from traditional radiology suites to critical care units and remote environments. This shift meets the urgent need for immediate stroke diagnosis and brain monitoring in patients who cannot be safely transported to high-field magnets, effectively overcoming infrastructure hurdles such as the requirement for radiofrequency shielding. As reported by Hyperfine, Inc. in March 2025, the company sold 48 commercial Swoop portable MRI systems in 2024, resulting in a 17% revenue increase driven by growing hospital adoption. These low-field, wheeled systems remove the need for specialized facilities, thereby democratizing access to neuroimaging and enabling faster clinical decision-making directly at the patient's bedside.

Additionally, the emergence of helium-free and liquid-free MRI technology is gaining momentum as healthcare providers seek to lower operational risks associated with global helium shortages and complex quench pipe infrastructure. This trend involves the deployment of sealed magnet technologies that utilize negligible amounts of coolant, significantly reducing lifecycle costs and siting complexities compared to conventional wet magnets. According to a November 2025 press release from Royal Philips, the company has installed over 2,000 of its 1.5T BlueSeal helium-free MRI systems globally, saving more than 6 million liters of liquid helium to date. This technological evolution ensures continuous uptime during supply disruptions and supports sustainability goals, establishing helium-free magnets as a resilient standard for future brain imaging installations.

Key Market Players

  • Varian Medical Systems
  • General Electric Company
  • Siemens AG
  • Philips Healthcare
  • Toshiba Medical Systems
  • Hitachi Medical Systems
  • Esaote SpA
  • Sanrad Medical Systems Pvt. Ltd

Report Scope

In this report, the Global Brain Imaging and Neuroimaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Brain Imaging and Neuroimaging Market, By Imaging Type

  • Functional Magnetic Resonance Imaging (fMRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Electroencephalography (EEG)
  • Magnetoencephalography (MEG)
  • Near Infrared Spectroscopy (NIRS);

Brain Imaging and Neuroimaging Market, By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Brain Imaging and Neuroimaging Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Brain Imaging and Neuroimaging Market.

Available Customizations:

Global Brain Imaging and Neuroimaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Brain Imaging and Neuroimaging Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Imaging Type (Functional Magnetic Resonance Imaging (fMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magnetoencephalography (MEG), Near Infrared Spectroscopy (NIRS);)
    • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Brain Imaging and Neuroimaging Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Imaging Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Brain Imaging and Neuroimaging Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Imaging Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Brain Imaging and Neuroimaging Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Imaging Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Brain Imaging and Neuroimaging Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Imaging Type
        • 6.3.3.2.2. By End User

7. Europe Brain Imaging and Neuroimaging Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Imaging Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Brain Imaging and Neuroimaging Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Imaging Type
        • 7.3.1.2.2. By End User
    • 7.3.2. France Brain Imaging and Neuroimaging Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Imaging Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Brain Imaging and Neuroimaging Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Imaging Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Brain Imaging and Neuroimaging Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Imaging Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Brain Imaging and Neuroimaging Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Imaging Type
        • 7.3.5.2.2. By End User

8. Asia Pacific Brain Imaging and Neuroimaging Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Imaging Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Brain Imaging and Neuroimaging Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Imaging Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Brain Imaging and Neuroimaging Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Imaging Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Brain Imaging and Neuroimaging Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Imaging Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Brain Imaging and Neuroimaging Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Imaging Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Brain Imaging and Neuroimaging Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Imaging Type
        • 8.3.5.2.2. By End User

9. Middle East & Africa Brain Imaging and Neuroimaging Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Imaging Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Brain Imaging and Neuroimaging Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Imaging Type
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Brain Imaging and Neuroimaging Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Imaging Type
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Brain Imaging and Neuroimaging Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Imaging Type
        • 9.3.3.2.2. By End User

10. South America Brain Imaging and Neuroimaging Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Imaging Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Brain Imaging and Neuroimaging Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Imaging Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Brain Imaging and Neuroimaging Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Imaging Type
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Brain Imaging and Neuroimaging Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Imaging Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Brain Imaging and Neuroimaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Varian Medical Systems
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. General Electric Company
  • 15.3. Siemens AG
  • 15.4. Philips Healthcare
  • 15.5. Toshiba Medical Systems
  • 15.6. Hitachi Medical Systems
  • 15.7. Esaote SpA
  • 15.8. Sanrad Medical Systems Pvt. Ltd

16. Strategic Recommendations

17. About Us & Disclaimer